Navigation Links
WaveSense Blood Glucose Meter One of Few Brands to Pass Rigorous TNO Tests
Date:10/9/2007

the detection of a wide range of variables that can distort a glucose reading, these variables can be corrected through advanced signal processing algorithms in the meter, thus leading to accurate readings.

"Accuracy is the most important feature of any glucose monitoring system. If people are checking their blood sugar regularly, they may as well get a reliable number. Getting wildly fluctuating readings is one of the most discouraging aspects of monitoring. WaveSense products help users by providing consistent, repeatable results that they trust," says John Walsh, PA, CDE, Diabetes Clinical Specialist at Advanced Metabolic Care + Research in Escondido, CA, and author of Pumping Insulin: Everything You Need For Success On A Smart Insulin Pump. "And being one of the few meters that has passed TNO standards really speaks to the performance and quality of the WaveSense Meter."

The Wellion Linus, powered by WaveSense technology, also holds the CE Mark and is commercially available in many countries throughout Europe. The Wellion Linus is marketed as the WaveSense KeyNote and the Liberty Meter in the United States, the iTest in Canada, and the GracePro in China.


'/>"/>
SOURCE AgaMatrix
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies
2. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
3. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
4. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
5. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
6. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
7. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
8. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
9. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
10. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
11. Blood Levels of Paliperidone Extended-Release Tablets are Not Increased by Common Antidepressant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/6/2009)....Y., Jan. 6 In recent controlled s...ty of Memphis , scientists found that the patented... first and only proven ingredient to increase leve...asing blood nitrate/nitrate (NOx) in human subject...nables an increase in blood flow to the skeletal m...
(Date:1/6/2009)...PANY, N.J., Jan. 6 Pacira Pharmace...ical company, announced today that enrollment,has...ials to evaluate the,safety and efficacy of a sin...(DepoBupivacaine) for prolonged postoperative anal...hoidectomy and in total knee,arthroplasty (TKA) a...
(Date:1/5/2009)...SE, Calif., Jan. 5 Women undergoin...ne medication to help support early,pregnancy, bu...his medication,can be painful for patients. Form...administered by subcutaneous injection or vaginal ... patient tolerance. , With patient well-bei...
(Date:12/27/2008)...S, Bermuda, Dec. 23 Warn...day that one of its subsidiaries and Mayne Pharma ... Hospira, Inc., have filed lawsuits against each o...Mylan Pharmaceuticals Inc. ("Mylan") and Impax Lab...or the District of New Jersey for infringement of ...
Breaking Medicine Technology:US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 3NKTR 118 Shows Substantial Oral Bioavailability and Extended Half Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 1995 1NKTR 118 Shows Substantial Oral Bioavailability and Extended Half Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 1995 2NKTR 118 Shows Substantial Oral Bioavailability and Extended Half Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 1995 3NKTR 118 Shows Substantial Oral Bioavailability and Extended Half Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 1995 4NKTR 118 Shows Substantial Oral Bioavailability and Extended Half Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 1995 5NKTR 118 Shows Substantial Oral Bioavailability and Extended Half Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 1995 6UC San Diego researchers target tumors with tiny nanoworms 18615 1UC San Diego researchers target tumors with tiny nanoworms 18615 2UC San Diego researchers target tumors with tiny nanoworms 18615 3Linkwell Corporation Begins Training and Licensing Beijing Olympics Disinfection Teams 18614 1Linkwell Corporation Begins Training and Licensing Beijing Olympics Disinfection Teams 18614 2Linkwell Corporation Begins Training and Licensing Beijing Olympics Disinfection Teams 18614 3Linkwell Corporation Begins Training and Licensing Beijing Olympics Disinfection Teams 18614 4Catholic Charities Calls for Increased Support of Mothers in Need 3A 18612 1Catholic Charities Calls for Increased Support of Mothers in Need 3A 18612 2
...ed by FDA for long-term maintenance,treatment of C...bulized formoterol fumarate provides improved lung...anced patient quality of,life, and positive safety...e/ -- Data presented at the,International Conferen...ate that Perforomist (formoterol fumarate) Inhalat...
...s Blood Pressure in Obese and,Non-Obese Hypertensi...stCall/ -- Forest,Laboratories, Inc. today present... pooled analysis of nebivolol, a selective beta,1-...er review by,the U.S. Food and Drug Administration...m the two clinical studies show that,nebivolol dem...
Other Medicine Technology:Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 2Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 3Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 4
(Date:1/8/2009)...ore effectively than Zocor , , THURSDAY,... review, U.S. health officials said Thursday that ...ial cholesterol-lowering drug Vytorin. , The U....significant difference in carotid artery thickness...ng the drug Zocor. , But, the agency reported, ...
(Date:1/8/2009)...tCall/ -- Allscripts-Misys Healthcare,Solutions, ...c. (Allscripts or,the Company), today announced i... ended November 30, 2008. , (Logo: http://...GO-b ) , The Company,s results for the thre...results from legacy Allscripts for the period of O...
(Date:1/8/2009)...swire/ -- The Pew Charitable Trusts announced toda...ical and food safety programs, in its Health &...merly deputy staff director and general counsel of...rks, brings nearly 25 years of experience in envir... , "We are excited to be joined by such an experi...
(Date:1/8/2009)...hristine Siu and Jason Brown, Ph.D. Promoted to Vi... STAMFORD, Conn., Jan. 8 Thomas, M...tal firm that invests in life science and medical ...n of three members of its investment team. Kathy ...u and Jason Brown have been promoted to Vice Presi...
Breaking Medicine News(10 mins):Health News:FDA Backs Cholesterol Drug Vytorin 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Thomas, McNerney & Partners Promotes Three Members of Its Investment Team 2
... the most common and deadly cancer worldwide. Abou...this year out of which // 85% will die before 2010...tries, but it is fastly increasing in low and midd...lung cancer occurrence is smoking. Globally smokin...
...by the Temple University School of Medicine report...c floor disorders often do not report their discom... that eventually when they do report to their medi...ften complicated and of urogynecological nature. P...
...tories (RL) has received its first tentative appro... ) to manufacture // and market lamivudine tablets... retroviral agents (ARVs) to treat patients with H...fter a number of quality checks and inspections by...
...e identified an enzyme’s new role in aiding joint ...enzyme called cathepsin G can regulate the ability...l start the process of inflammatory conditions tha...athepsin G attracts accumulation of immune cells t...
Other Medicine News:Health News:Aggressive Tobacco taxation policy can reduce cigarette smoking, 2
...ct Complete® is a scientifically advanced nutr...ion for macular and full body health. MacularProte...nd other advanced research. It features a comprehe...d foundation of antioxidants, such as 10 mg of Flo...
Oculair (re-formulated Syntrx Complete) is a potent full-spectrum multiple vitamin/mineral/antioxidant dietary supplement that supports the normal aging process. It is designed to reflect the most re
Ocuvite® vitamin and mineral supplements contain 2 mg of Lutein 8 times more than the leading multivitamins. Ocuvite also contains vitamin antioxidants A, C and E, as well as the minerals zinc,
Most people take their eyes for granted. Like the rest of your body, your eyes need proper nutrition and care to help maintain eye health and vision as you age. In fact, research indicates proper nut
Medicine Products: